Just as CD18-mutant mice are protected against MCD-mediated liver injury, mice with targeted disruption of genes encoding pro-inflammatory cytokines, cytokine receptors, and TLRs are also able to resist experimental fatty liver disease [28, 31, 57–59]. The gene discussed is ITGB2; the disease is fatty liver disease.